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HMGB1 promotes hair growth via 
the modulation of prostaglandin 
metabolism
Ji-Hye Hwang1, Howard Chu1, Yuri Ahn1, Jino Kim2 & Do-Young Kim  1
Unexpected hair growth can occur after tissue injury. The pathogenic mechanism for this phenomenon 
is unknown but is likely related to inflammatory mediators. One such mediator is high-mobility group 
box 1 (HMGB1), a ubiquitous nuclear protein that is released from cell nuclei after tissue damage. To 
elucidate the effect of HMGB1 on hair growth and understand its mechanism of action, we evaluated 
the effect of HMGB1 treatment on hair shaft elongation and on mRNA and protein expression in 
cultured human dermal papilla cells (hDPCs). HMGB1 enhanced hair shaft elongation in an ex vivo hair 
organ culture. In hDPCs, HMGB1 treatment significantly increased mRNA and protein expression levels 
of prostagladin E synthases. HMGB1 also stimulated prostaglandin E2 (PGE2) secretion from hDPCs. 
Finally, blocking the receptor for advanced glycation end-products, a canonical HMGB1 receptor, 
inhibited HMGB1-induced PGE2 production and hair shaft elongation. Our results suggest that HMGB1 
promotes hair growth via PGE2 secretion from hDPCs. This mechanism can explain the paradoxical 
phenomenon of trauma-induced hair growth. Thus, HGMB1 can be a viable therapeutic target for the 
treatment of alopecia.
Tissue injury can incidentally induce unexpected hair growth. For example, laser-induced paradoxical hyper-
trichosis occurs in 0.01~1.9% of patients treated with laser epilation1. Head and neck surgery, ultraviolet radia-
tion exposure, and viral infection are also associated with hypertrichosis2–4. This phenomenon is likely related 
to inflammatory mediators and sub-therapeutic thermal injury causing induction of the hair cycle5; however, 
the exact cause is unknown. Overall, this mechanism of post-trauma or post-inflammatory hypertrichosis likely 
involves multiple biochemical mediators4.
One class of potential mediators is damage-associated molecular patterns (DAMPs). DAMPS are intracellular 
molecules released by injured tissues6. A canonical DAMP is high-mobility group box 1 (HMGB1), a ubiquitous 
nuclear non-histone protein. This small nuclear protein is involved in DNA transcription, replication, repair, and 
compaction7. Under conditions of stress or damage, HMGB1 is released actively or passively from various cells 
and acts as a critical factor in acute tissue injury8,9.
HMGB1 has also been implicated in regeneration processes. Under the influence of HMGB1, stem cells move 
toward an area of inflammation, contributing to tissue regeneration10. Furthermore, HMGB1 inhibition delays 
wound healing in normal mice, confirming its importance to tissue repair11. However, whether HMGB1 and its 
signalling partners play a role in hair growth is unknown. Because it is released upon injury, HMGB1 may have 
a role in post-traumatic or post-inflammatory hypertrichosis. In this study, we evaluated the effect of HMGB1 
on hair shaft elongation in an ex vivo hair organ culture model and investigated the possible mechanisms of 
HMGB1-induced hair growth.
Results
HMGB1 stimulates hair shaft elongation in human hair follicles. Treatment with 25 to 200 ng/
ml of HMGB1 enhanced hDPC proliferation in vitro without toxicity in a dose-dependent manner (p < 0.05; 
Supplementary Fig. 1). However, HMGB1 concentrations above 500 ng/ml were cytotoxic (data not shown). 
Accordingly, an HMGB1 concentration of 200 ng/mL was used for subsequent experiments.
To assess the role of HMGB1 on anagen hair follicles, lower anagen hair follicles micro-dissected from healthy 
human scalps were cultured with 200 ng/mL recombinant human HMGB1 or 1 μM minoxidil for 9 days. Changes 
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in hair shaft lengths over time were measured. This revealed that HMGB1 treatment significantly increased hair 
elongation (p < 0.001; Fig. 1a,b) relative to untreated control follicles. This HMGB1-induced enhancement was 
comparable with 1 μM minoxidil, a representative positive control. Importantly, this effect became significant for 
both the HMBG1 and minoxidil treated groups beginning at 6 days. We also assessed the percentage of anagen 
and catagen hairs, which revealed that 56% of hair follicles remained in anagen after 9 days when cultured with 
HMGB1 relative to only 33% for untreated controls (Fig. 1c).
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Figure 1. HMGB1 stimulates hair shaft elongation in human hair follicles. Isolated human hair follicles were 
treated with 200 ng/ml HMGB1 or 1 μM minoxidil for 9 days. (a) The photo panels show representative hair 
follicles from each group at day 0 (left) and 9 (right). Scale bar = 1 mm (b) Quantification of hair shaft growth 
rates. Changes in hair shaft length were measured using a stereomicroscope at 3, 6, and 9 days after culturing 
the cells. Data are shown as the mean ± SD of five independent donors (at least 90 follicles in each experiment). 
p-values were determined by ANOVA followed by Bonferroni post-hoc test. # p < 0.05, comparison between 
HMGB1 vs. control; *p < 0.05, comparison between minoxidil vs. control. (c) The percentage of hair follicles 
in each cycle stage at 9 days after treatment with 200 ng/ml HMGB1 or 1 μM minoxidil was assessed by 
morphological analysis. Data are shown as mean ± SD. (d) Immunofluorescence staining for Ki-67 (green) 
was performed after incubation of hair follicles with 200 ng/ml HMGB1 or 1 μM minoxidil for 3 days. 
4′-6-diamidino-2-phenylindole (DAPI; blue) was used to counterstain the nuclei. Scale bar = 50 μm. (e) Ki-67+ 
positive cells in the matrix region were quantified. The results are shown as mean ± SD of three independent 
experiments. *p < 0.05 and **p < 0.01 compared with control group using one-way ANOVA.
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Figure 2. HMGB1 increases prostaglandin E synthase transcription in human dermal papilla cells (hDPCs). 
(a) mRNA expression of cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), microsomal prostaglandin 
E synthase-1 (mPGES-1), microsomal prostaglandin E synthase-2 (mPGES-2), cytosolic prostaglandin E 
(cPGES), aldo-keto reductase family 1 member C1 (AKR1C1), aldo-keto reductase family 1 member C3 
(AKR1C3), carbonyl reductase-1 (CBR-1), prostaglandin D synthase (PTGDS), alkaline phosphatase (ALPL), 
and vascular endothelial growth factor (VEGF) was examined in hDPCs treated with 100 or 200 ng/ml HMGB1 
by real-time PCR analysis. The relative mRNA levels were normalized to GAPDH. The results are expressed 
as mean ± SD of three independent experiments. *p < 0.05 and **p < 0.01 compared to control group using 
ANOVA. (b) hDPCs were treated with 200 ng/ml HMGB1 for different incubation periods (0.5, 1, 2, and 4 h). 
The protein levels of COX-1, COX-2, mPGES-1, mPGES-2, and cPGES were measured using western blot 
analysis. β-actin served as a loading control. The results are expressed as mean ± SD of three independent 
experiments. *p < 0.05, **p < 0.01, and ***p < 0.001 compared with control group using one-way ANOVA 
followed by Bonferroni’s test. Representative images of immunofluorescence staining for (c) COX-1, (d) COX-
2, and (e) mPGES-1 in hDPCs cultured with 200 ng/ml HMGB1 for 30 min. 4′-6-diamidino-2-phenylindole 
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We next wanted to determine the effect of HMGB1 on hair follicle proliferation. Immunofluorescence anal-
ysis using Ki-67 as a marker for proliferation (Fig. 1d) revealed that HMGB1 treatment for 3 days significantly 
increased the hair follicle proliferation rate (32.5%) compared with untreated controls (9.1%; p < 0.01). This 
effect was also comparable to that of minoxidil (Fig. 1e). These findings suggest that HMGB1 is a novel hair 
growth-promoting mediator.
HMGB1 increases PGE2 synthases and PGE2 production in hDPCs. Dermal papilla, an aggregate 
of specialized fibroblasts located at the proximal end of a hair follicle, plays key roles in regulation of follicular 
development and hair cycle and supplies inductive signals required for proliferations of matrix keratinocytes12. 
To investigate possible signalling pathways involved in HMGB1-induced hair shaft elongation, we first used a 
growth factor array to screen the secretome of hDPCs. HMGB1 did not significantly increase the production of 
any growth factors screened (Supplementary Fig. 2). Because prostaglandins have recently been recognized as key 
growth regulating factors13, we next performed quantitative RT-PCR to quantify the mRNA levels of prostaglan-
din synthases in hair bulbs. This revealed that HMGB1 treatment substantially upregulated mRNA expression 
of PGE2 synthases, mPGES-1, mPGES-2, and cPGES in hDPCs (Fig. 2a). Specifically, we observed a 1.2-fold 
increase in mPGES-1 expression, a 2-fold increase in mPGES-2, and a 1.5-fold increase in cPGES relative to con-
trol treatment. No significant changes were observed in the mRNA levels of PGF2a synthases, AKRIC1, AKRIC3, 
and CBR1, and PGD2 synthase PTGDS when treated with HMGB1. Hence, further experiments were focused on 
PGE2 and HMGB1.
To verify the changes we observed in mRNA expression, we next measured the protein levels of PGE2 syn-
thases by western blot. The experiments were performed in accordance with the finding of early induction of 
COX in previous studies14,15. This revealed that HMGB1 treatment significantly increased protein expression of 
COX-1, COX-2, mPGES-1, and mPGES-2 in hDPCs by approximately 1.5-fold relative to the control (Fig. 2b). 
Importantly, these increases occurred within 0.5 h of HMGB1 treatment. These results were visualized and con-
firmed using immunofluorescent staining (Fig. 2c–e).
Furthermore, ELISA analysis confirmed that HMGB1 treatment significantly elevated PGE2 secretion from 
hDPCs at 4 hours post-treatment (Supplementary Fig. 3). We also observed that this effect of HMGB1 on PGE2 
production was in a dose-dependent manner (Fig. 2f). In order to verify the different effects of HMGB1 depending 
on its chemical forms, we tested subunits of HMGB1 and a form with different redox status. Both box A and B did 
not induce PGE2 production (Supplementary Fig. 4a). Pre-treatment of 5 mM dithiothreitol (DTT) can reduce a 
disulfide form of HMGB1 which we used (R&D Systems, #1690-HMB-050, Supplementary Fig. 4b). Interestingly, 
both redox forms of HMGB1 similarly increased PGE2 production (Supplementary Fig. 4c). Collectively, subunit 
of HMGB1 alone is not sufficient to induced PGE2 production but either redox forms of HMGB1 can stimulate 
PGE2 production in hDPCs. To explore biological relevance, we tested HMGB1 in organ culture model. HMGB1 
increased expressions of COX-1 and mPGES-1, which was confirmed by confocal microscopy in isolated human 
hair follicle after treating with 200 ng/ml HMGB1 for three days. Immunofluorescent analysis also revealed that 
HMGB1 or minoxidil treatment both increased COX-1 and mPGES-1 expression in hair follicles compared to 
control levels (Fig. 3).
RAGE is the target receptor for HMGB1-induced PGE2 production. Because HMGB1 binds to var-
ious target receptors, including TLR2, TLR4 and RAGE, we next wanted to determine the receptor pathway 
related to HMGB1-induced signalling in hDPCs. First, the effect of HMGB1 on RAGE was evaluated, which 
revealed that RAGE expression substantially increased in a time-dependent manner until 4 hours of HMGB1 
treatment, and then subsequently decreased (Supplementary Fig. 5). Interestingly, treatment with a RAGE inhibi-
tor, RAGE-FC, directly abrogated HMGB1-induced COX1, COX2, mPGES-1 and mPGES-2 expression in hDPCs 
(Fig. 4a,b). Specifically, while treatment with HMGB1 increased expression of these proteins by 1.5 to 2-fold, their 
expression returned to control levels when pre-treated with RAGE-FC (Fig. 4b). Similarly, the RAGE inhibitor 
suppressed the HMGB1-induced increase in PGE2 secretion from cultured hDPCs (Fig. 4c). These results were 
confirmed by immunofluorescent staining (Fig. 4d,e and Supplementary Fig. 6). However, the expressions of 
mPGES-1 and mPGES-2 were not altered by blocking antibodies against TLR2 and TLR4, other target recep-
tors for disulfide-HMGB1 (Supplementary Fig. 7a). Instead, PGE2 production by reduced form was blocked by 
anti-TLR4 antibody but not by RAGE-FC (Supplementary Fig. 7b,c), which suggests modification in redox status 
of HMGB1 can affect its binding affinity to different target receptors. Collectively, these data suggest that HMBG1 
increases PGE2 production in hair follicles via RAGE particularly for the disulfide-HMGB1.
RAGE blockade inhibits HMGB1-induced hair shaft elongation in human hair follicles. Finally, 
we wanted to evaluate the effect of RAGE inhibition on HMGB1-induced hair shaft elongation. To test this, hair 
follicles were pre-treated with RAGE-FC for 1 hour prior to HMGB1 treatment for 9 days, and then hair shafts 
elongation was measured. Importantly, hair follicles treated with HMGB1 and RAGE inhibitor were significantly 
shorter than those treated with HMGB1 alone (Fig. 5a,b). Immunofluorescent staining revealed that HMGB1 
significantly increased COX-1 and mPGES-1 expression in the dermal papilla, while RAGE-FC pre-treatment 
(DAPI; blue) was used to counterstain the nuclei. Data are representative of three independent experiments. 
Scale bar = 20 μm. (f) PGE2 secretion from hDPCs was determined by ELISA following treatment with various 
concentrations of HMGB1 (50, 100, and 200 ng/ml) for 4 h. The results are expressed as mean ± SD of three 
independent experiments. *p < 0.05 compared with control group using one-way ANOVA.
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inhibited this effect and returned their expression to control levels (Fig. 5c). These findings confirm that HMGB1 
induces hair shaft elongation through RAGE signalling.
Discussion
In this study, we selected HMGB1, a key DAMP, as a candidate mediator of trauma- or inflammation-induced hair 
growth. We confirmed that HMGB1 stimulated hair follicle elongation in an ex vivo hair organ culture and PGE2 
secretion from hDPCs. Importantly, blocking RAGE inhibited HMGB1-induced expression of PGE2 synthases. 
These results suggest that HMGB1 induces PGE2 secretion from hDPCs through RAGE signalling, and that PGE2 
stimulates the proliferation of neighbouring follicular matrix keratinocytes to enhance hair shaft elongation.
Prostaglandins regulate a variety of physiological activities such as inflammation, platelet aggregation, neu-
rotransmitter release, and smooth muscle contraction16. One prostaglandin subset, prostaglandin D2, inhibits 
hair follicle elongation and promotes the onset of catagen, leading to the miniaturization of the hair follicle in 
androgenetic alopecia13. By contrast, PGE2 promotes hair growth in both mice and humans. Indeed, PGE2 treat-
ment induces rapid hair growth after depilation, and subcutaneous or topical administration of 16,16-dimethyl 
PGE2 prevents radiation-induced alopecia in mice17,18. Furthermore, treatment with viprostol, a PGE2 analogue, 
increases hair growth in humans19. PGE2 also modulates cell proliferation and viability20–22. Thus, prostaglandins, 
particularly PGE2, are critically involved in hair growth.
PGE2 has also been previously associated with HMGB1. Specifically, HMGB1, in complex with IL-1β, induces 
mPGES-1 and PGE2 in synovial fibroblasts from patients with rheumatoid arthritis23. HMGB1, together with 
IL-1β, also activates COX-2 and mPGES-1, significantly increasing the production of PGE2 in vascular smooth 
muscle cells24. As in previous studies, in our study, HMGB1 induced PGE2 production in hDPCs, a specialized 
subset of fibroblasts. This PGE2 production promoted hair shaft elongation. Importantly, DP express prostaglan-
din E receptors, which bind PGE2 25, so HMGB1-induced PGE2 production could also promote hair growth by 
regulating DP activity in an autocrine and/or paracrine manner22,25.
In this study, the growth-promoting effects of HMGB1 were RAGE-dependent. RAGE binds many ligands, 
including HMGB1, and its expression has been found to be increased under acute or chronic inflammatory 
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Figure 3. HMGB1 increases prostaglandin E synthase expression in human hair follicles. (a) Hematoxylin and 
eosin staining on the lower part of a cultured hair follicle. DP, dermal papilla. (b) Immunofluorescence staining 
for COX-1 (red) and mPGES-1 (green) in human hair follicles after 3 days of treatment with 200 ng/ml HMGB1 
or 1 μM Minoxidil. 4′-6-diamidino-2-phenylindole (DAPI; blue) was used to counterstain the nuclei. Data are 
representative of ~4–5 hair follicles per each condition from three independent experiments. Scale bar = 50 μm.
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Figure 4. RAGE is the corresponding receptor for HMGB1 in hDPCs. Blocking RAGE (RAGE-FC) inhibited 
the effects of HMGB1 on prostaglandin metabolism. Cultured hDPCs were pre-treated with or without 10 μg/
ml RAGE-FC for 30 min and then incubated with 200 ng/ml HMGB1 for 30 min. (a) The protein levels of 
COX-1, COX-2, mPGES-1, and mPGES-2 were measured using western blot analysis. (b) Protein bands were 
analysed using densitometry, and β-actin served as a loading control. The results are expressed as mean ± SD 
of three independent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001 compared with control group using 
one-way ANOVA followed by Bonferroni’s test. (c) PGE2 production from cultured hDPCs was measured using 
ELISA. Cultured hDPCs were pre-treated with 10 μg/ml RAGE-FC for 30 min and then incubated with 200 ng/
ml HMGB1 for 4 h. Data are representative of three independent experiments. The results are expressed as 
mean ± SD of three independent experiments. **p < 0.01 and ***p < 0.001 compared with control group using 
one-way ANOVA. Representative images of immunofluorescence staining for (d) COX-1 (red), (e) COX-2 
(red), and mPGES-1 (green) in hDPCs pre-treated with 10 μg/ml RAGE-FC for 30 min and 200 ng/ml HMGB1 
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conditions26. RAGE signalling can also significantly increase PGE2 production from endothelial cells and syn-
oviocytes27,28. Similarly, in our study, blocking RAGE inhibited PGE2 synthases, suggesting that PGE2 secretion 
from DPCs occurs through RAGE signalling. HMGB1, a RAGE ligand, is passively released from various cells 
during cellular necrosis and inflammation, but particularly from activated myeloid cells9,29. Rapidly released by 
damaged tissues, HMGB1 is an early stage mediator in trauma30. It also contributes to tissue repair by modulating 
chemotaxis, neoangiogenesis, and cell proliferation31,32. To our knowledge, our results are the first to show that 
HMGB1 also promotes hair growth.
Recently, growing evidences revealed that interaction between different redox forms of HMGB1 and their 
affinity of various target receptors is getting more complex33–35. From our observation, both forms of HMGB1, 
disulphide- and reduced-HMGB1, have potential capability to induce PGE2 from hDPCs but their primarily 
responding receptors can vary depending on redox status.
Counterintuitively, previous studies in alopecia areata have shown the contradictory effect of HMGB1 on hair 
follicle growth36. HMGB1 levels are significantly higher in the tissue and sera of these patients. But HMGB1 effect 
in alopecia areata results from its immunostimulating action, which eventually induces the apoptosis of the hair 
follicle keratinocyte driven by autoimmune response37. And other factors including concentration of HMGB1 in 
the local milieu can determine the consequence. For example, the migration and chemotaxis of polymorphonu-
clear neutrophils is inhibited at low HMBG1 concentrations, but enhanced at high concentrations38. Therefore, 
future studies are needed to understand such double-sided biological effect of HMGB1 in a complicated envi-
ronment such as inflamed hair follicles. In summary, our results demonstrated that HMGB1, an inflammatory 
mediator, markedly stimulated hair shaft elongation in both in vitro and ex vivo models by stimulating PGE2 
production. This effect was dependent on RAGE, and blocking this receptor attenuated the effects of HMGB1 
on hair growth. Thus, HMGB1 signalling may explain the paradoxical hypertrichosis that occurs following laser 
epilation and hypertrichosis in other inflammatory or traumatic circumstances. Ultimately, our study suggests 
that HMGB1 may be a novel therapeutic target for hair growth and alopecia treatment.
Methods
Hair follicle sources and isolation of dermal papilla cells. This study was approved by the Institutional 
Review Board at Severance Hospital, and all sample donors provided written informed consent. All experimental 
procedures using human materials were conducted according to the Declaration of Helsinki Principles.
Occiput scalp skin containing mainly anagen VI hair follicles was obtained from disposed excess skin samples 
derived from patients undergoing elective plastic surgery. Hair follicles were isolated under a stereo dissecting 
microscope, and dermal papilla were separated from individually isolated hair follicles as previously described39. 
Hair follicles that were morphologically considered to be in anagen were used in this study.
Cultivation of isolated dermal papilla cells. Dermal papilla cells (hDPCs) were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM; Hyclone, Logan, UT, USA) supplemented with 10% fetal bovine serum (FBS; 
Hyclone) and antibiotic/antimycotic solution (Gibco BRL, Gaithersburg, MD, USA) containing penicillin and 
streptomycin. Cells were incubated at 37 °C in a 5% CO2 incubator. All cultures used for experiments were in the 
third or fourth passage. Depending on the experiment, the media were supplemented with different concentra-
tions of recombinant human HMGB1 (HMGB1; R&D systems, Minneapolis, MN, USA) or HMGB1 with anti-
bodies blocking receptor for advanced glycation end-products (RAGE-FC, R&D systems), anti-TLR2 (BioLegend, 
San Diego, CA, USA), or anti-TLR4 (eBiosicence, San Diago, CA, USA) neutralizing antibodies. For the analysis 
on the effects of different forms of HMGB1, 200 ng/ml of A-box and 200 ng/ml of B-box (HMGBiotech, Milano, 
Italy), and 5 mM of dithiothreitol (DTT; Sigma–Aldrich, St. Louis, MO, USA) were used.
Hair follicle organ culture. Normal human scalp skin hair follicles in the anagen VI stage of the hair cycle40 
were isolated as previously described41 with slight modifications. Briefly, after separation of the hair follicles under 
a binocular dissecting microscope, the proximal two-thirds of anagen hair follicles located in the subcutaneous 
fat were isolated using watchmakers forceps, and subsequently collected in a 35-mm culture dish containing 
complete hair follicle culture medium (Williams E; Gibco BRL) supplemented with 2 mM/L-glutamine (Gibco 
BRL), 10 ng/ml hydrocortisone (Sigma-Aldrich, St Louis, MI, USA), and 10 μg/ml insulin (Invitrogen, Carlsbad, 
CA, USA). Three isolated hair follicles were then cultured for 9 days in each individual wells of a 24-well plate 
containing 500 µL of complete hair follicle culture medium. Depending on the experiment, the media were sup-
plemented with different concentrations of recombinant human HMGB1 (R&D systems) or HMGB1 with anti-
bodies blocking receptor for advanced glycation end-products (RAGE-FC, R&D systems). A positive control, 
minoxidil (Sigma–Aldrich, St. Louis, MO, USA) was used in a concentration of 1 μM. The culture medium was 
replaced every two days. Each experiment was repeated with hair follicles harvested from different donors. Every 
third day, photographs of the hair shafts were taken, and the length of each hair follicle was measured. The hair 
cycle stage of each follicle was assessed and classified by morphological criteria40,42.
Methyl thiazolyl-diphenyl-tetrazolium bromide (MTT) cell viability assay. The influence of 
HMGB1 on hDPC proliferation was assessed by MTT cell proliferation assay43. hDPCs were seeded at a density 
of 1.6 × 103 cells/well on 96-well plates. After 18 h of incubation, the cells were washed with PBS and cultured for 
24 h within 200 μl of FBS-free DMEM, together with the indicated concentrations of HMGB1. Then, the medium 
treatment for another 30 min. 4′-6-diamidino-2-phenylindole (DAPI; blue) was used to counterstain the nuclei. 
White arrowheads mark the expression of each enzyme in perinuclear region of hDPCs. Data are representative 
of three independent experiments. Scale bar = 20 μm.
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was removed and 100 μl of 5 mg/ml MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] 
(Sigma–Aldrich, St. Louis, MO, USA) in PBS was added. At the end of 4 h incubation, the plates were centri-
fuged, and the untransformed MTT was removed. After 100 μl of dimethyl sulfoxide (DMSO; Sigma-Aldrich, 
St. Louis, MI, USA) was added to each well, the plates were shaken for 10 min. The optical density at 570 nm was 
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Figure 5. RAGE blockade inhibits HMGB1-induced hair shaft elongation in human hair follicles. Human 
hair follicles were pre-treated with 10 μg/ml RAGE-FC for 1 h followed by 200 ng/ml HMGB1 for 9 days. (a) 
Representative photos of hair follicles from each group are shown. (b) Quantification of hair shaft growth rates. 
The changes in hair shaft lengths were quantified at 6 and 9 days using a stereomicroscope. Data are shown as 
the mean ± SD of five independent donors (at least 120 follicles for each experiment. p-values were determined 
by ANOVA followed by Bonferroni test. **p < 0.01 and ***p < 0.001 compared with control group. (c) Human 
hair follicles were pre-treated with 10 μg/ml RAGE-FC for 1 h followed by 200 ng/ml HMGB1 for 3 days. 
Representative confocal images of hair follicles stained with COX-1 (red) and mPGES-1 (green) are shown. 
4′-6-diamidino-2-phenylindole (DAPI; blue) was used to counterstain the nuclei. On day 3, each hair follicle was 
frozen and cryosectioned (6 μm). Data are representative of three independent experiments. Scale bar = 50 μm.
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determined using an ELISA reader. The cell viability rates were calculated from the optical density (OD) readings 
and are represented as percentages of the control value (untreated cells).
Enzyme-linked immunosorbent assay (ELISA) for PGE2. Prostaglandin E2 concentrations in the 
medium from cultured hDPCs were measured by enzyme immunoassay (EIA kit; Cayman Chemicals, Ann 
Arbor, MI, USA) according to the manufacturer’s instructions. Briefly, the hDPCs were cultured in triplicates at 
7.5 × 104 cells/ml onto 48-well plates. After 18–24 h of incubation, the cells were washed with PBS and cultured 
in serum-free condition for 24 h. hDPCs were incubated with HMGB1 at different time points (0, 0.5, 1, 2, and 
4 h) or stimulated with 200 ng/ml HMGB1 for 4 h followed by RAGE-FC for 30 min, respectively. Then, 50 µl of 
cultured medium was incubated in goat anti-mouse IgG-coated plates with a PGE2-acetylcholinesterase conjugate 
(PGE2 tracer) and PGE2 monoclonal antibody overnight at 4 °C. Finally, 200 µl of Ellman’s reagent was added to 
each well for 90 min at room temperature and the plate was read at 412 nm.
Human cytokine array analysis. Supernatant of hDPCs cultured with or without 200 ng/ml HMGB1 
was collected at 48 h. Levels of multiple cytokines were assayed using the Human Growth Factor Antibody 
Array (Abcam, Cambridge, UK) following the manufacturer’s instructions. Briefly, array membranes immobi-
lized with capture antibodies were incubated with 1 ml of the supernatant for 1 h at room temperature. Then, a 
biotin-conjugated detection antibody cocktail was added to the membranes for overnight at 4 °C. The membranes 
were then incubated with horseradish peroxidase-conjugated streptavidin, and signal was detected using an ECL 
Plus kit (Millipore Corporation, Billerica, MA, USA). Images of each array were captured by LAS-4000 (GE 
Healthcare, Pittsburgh, PA, USA). The signal intensity was calculated using Image J (NIH, Bethesda, MD, USA).
Protein extraction and western blot. Protein expression was assessed with western blots. Briefly, col-
lected cells were lysed with RIPA lysis buffer (GenDEPOT, Houston, TX, USA), and protein concentration was 
quantified using the BCA assay. Protein samples were then resolved by SDS-PAGE and transferred onto a nitro-
cellulose membrane (GE Healthcare). After blocking, the membranes were incubated with the respective pri-
mary mouse antibodies: anti-cyclooxygenase-1 (COX-1; 1:1000), anti-cyclooxygenase-2 (COX-2; 1:500; Abcam, 
Cambridge, UK), anti-microsomal PGE synthase-1 (mPGES-1; 1:1000), anti-microsomal PGE synthase-2 
(mPGES-2; 1:500), anti- cytosolic PGE synthase (cPGES; 1:200; Cayman Chemicals), or anti-β-actin (1:1000; 
Cell Signalling Technology, Beverly, MA, USA). The membranes were then incubated with peroxidase-conjugated 
affinity-purified goat anti-rabbit IgG or goat anti-mouse IgG secondary antibody (1:10000; GenDEPOT), and the 
protein bands were detected using an ECL Plus kit (Millipore Corporation, Billerica, MA, USA).
RNA isolation and quantitative real-time PCR. Total RNA from cells was isolated with Trizol rea-
gent (Qiagen GmbH, Hilden, Germany). For real-time PCR (RT-PCR), purified RNA was oligo(dT)-primed 
for first-strand cDNA synthesis (Superscript III kit; Invitrogen). A quantitative SYBR Green RT-PCR kit 
(Applied Biosystems, Warrington, UK) was used with a Step One Plus RT-PCR System (Applied Biosystems). 
Quantitative RT-PCR was performed using the following sequence-specific primers: GAPDH (forward: 
5′-TGGAAATCCCATCACCATCTTC-3′ and reverse: 5′-CGCCCCACTTGATTTTGG-3′), COX-1 (forward: 
5′-TGCGCTCCAACCTTATCCC-3′ and reverse: 5′-AGAGGGCAGAATACGAGTGTAA-3′), COX-2 (forward: 
5′-CTGGCGCTCAGCCATACAG-3′ and reverse: 5′-CGCACTTATACTGGTCAAATCCC-3′), mPGES-1 (for-
ward:5′-GAAGAAGGCCTTTGCCAACC-3′ and reverse: 5′-ATGGTCTCCATGTCGTTCCG-3′), mPGES-2 
(forward:5′-TACCAGGTGGTGGAGGTGAA-3′ and reverse: 5′-TGCGAGCTTTCTCCTTCCTG-3′), cPGES 
(forward: 5′-TGGCTTAGTGTCGACTTCAAT-3′ and reverse: 5′-TCCTCATCACCACCCATGTTG-3′), 
aldo-keto reductase family 1 member C1 (AKR1C1) (forward: 5′-TTGCATGAGGTCTGCCA-3′ and 
reverse: 5′-GCTGTAGCTTGCTGAAAT-3′), aldo-keto reductase family 1 member C3 (AKR1C3) (for-
ward: 5′-GCCTGTATTGGGATTTGGCAC-3′ and reverse: 5′-TCTATATGGCGGAACCCAGC-3′), 
carbonyl reductase 1 (CBR1) (for ward:  5 ′-AAGAT TGGCGTCACCGT TCT-3 ′  and reverse: 
5 ′ -GTAAATGCCCT T TGGACCAACT-3 ′ ) ,  prostag landin-H2 D-isomerase  (PTGDS) ( for-
ward: 5′-AACCAGTGTGAGACCCGAAC-3′ and reverse: 5′-CTGACACGGAGTAGGTGCTG-3′), 
a lkal ine phosphatase (ALPL) (for ward:  5 ′-TCACTCTCCGAGATGGTGGT-3 ′  and reverse: 
5′-TTTCCTTCATGGTGCCCGT-3′), and vascular endothelial growth factor (VEGF) (forward: 
5′-CTGCTCTACCTCCACCATGC-3′ and revers: 5′-AGCTGCGCTGATAGACATCC-3′). The PCR was con-
ducted under the following conditions: Denaturation at 95 °C for 15 sec, 40 amplification cycles of annealing at 
60 °C for 30 sec, and extension at 72 °C for 30 sec. All samples were run in triplicate, and relative gene expression 
was determined using the 2−ΔΔCt method, with GAPDH as the normalization standard.
Immunofluorescence. Immunofluorescence staining was performed on hDPCs and 5-μm frozen sections 
of hair follicles. The hDPCs were plated in 8 chamber slides (LAB-TEK, Rochester, NY, USA) at a density of 
1.6 × 103 cells per well and cultured in serum-free DMEM with 200 ng/ml HMGB1 or with blocking antibodies.
Hair follicles and hDPCs were fixed in 4% paraformaldehyde for 15 min, and then permeabilized with 
0.1% Triton X-100 (Sigma-Aldrich) and blocked with 10% goat serum. The following primary antibodies were 
used: anti-Ki-67 (DAKO, Carpinteria, CA, USA), mouse anti-COX-1 (1:100; Abcam, Cambridge, MA, USA), 
FITC-conjugated anti-COX-2 (1:100; Abcam), rabbit anti-mPGES-1 (1:100; Cayman Chemicals) and rabbit 
anti-mPGES-2 (1:100; Cayman Chemicals). After washing with PBS, samples were incubated with the appro-
priate secondary antibodies: Alexa Fluor 488 goat anti-rabbit IgG, Alexa Fluor 635 goat anti-mouse IgG (Life 
Technologies, Eugene, OR, USA) and Alexa Fluor 635 goat anti-rabbit (Abcam). Slides were washed in PBS and 
counterstained with 4,6-diamidino-2-phenylindole (DAPI) (Life Technologies). Immunofluorescence images 
were acquired using Zeiss LSM 700 confocal laser scanning microscopy software (Carl Zeiss, Oberkochen, 
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Germany). For quantitative analyses, Ki-67-positive cells were counted and normalized to the number of 
DAPI-stained cells using ZEN 2009 software (Carl Zeiss).
Statistical analysis. Statistical analyses were conducted using Graph Pad Prism, version 4.03 (GraphPad 
Software, Inc., San Diego, CA, USA). Data are expressed as mean ± SD for parametric data, and as median and 
interquartile range for nonparametric data. The significance of differences between two groups was determined 
using a two-tailed Student’s t-test or Wilcoxon signed ranks test. For multiple comparisons, a one-way ANOVA 
with a Bonferroni test was used. A P-value < 0.05 was considered statistically significant. Significance is indicated 
in the figures as follows: *P < 0.05; **P < 0.01; ***P < 0.001.
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